ArticleScience advances2024
Near-infrared light-driven biomass conversion.
Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Modular Core-Substituted Naphthalenediimide-Based Metal-Organic Frameworks for Red-Light-Driven Photocatalysis.Angewandte Chemie (International ed. in English) · 2026Article
- Near-Infrared-Responsive Catalysts for Gas-Solid Phase Photocatalytic COChemistry (Weinheim an der Bergstrasse, Germany) · 2026Review
- Photoreforming and Photoelectroreforming of Waste-Derived Feedstocks for Solar-Driven Production of Fuels and Chemicals.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Quantitative Photo-Reforming of Biomass to CO Spurred by In Situ Protonation of Carbon Dioxide Radical Anions.Angewandte Chemie (International ed. in English) · 2026Article
- Tuned Oxidation Potential of Continuous Defective Photocatalyst for Selective Biomass Conversion.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Micellization of Organic Conjugated Polymers toward Functional Nanomaterials for Photocatalytic Applications.Chem & bio engineering · 2026Review
- Near-infrared-driven photocatalytic CONature communications · 2026Article
- Gaussian curvature engineering of self-pressurizing mesoporous nanoreactors boosts dynamic equilibrium of molecule adsorption-desorption.Nature communications · 2025Article
- Biomolecule-tailored chiral nickel oxide nanozymes amplify autophagy-mediated tumor ablation via synergistic photodynamic-chemodynamic therapy.Materials today. Bio · 2025Article
- Precise Engineering of Asymmetric Tri-Active Sites by Symbiotic Strategy for Photocontrolled Directional Reforming of Biomass.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current photocatalytic technologies mainly rely on the input of high-energy ultraviolet-visible (UV-vis) light to obtain the desired excited states with adequate energy to drive redox reactions, precluding the use of low-energy near-infrared (NIR) light that occupies ~50% of the solar spectrum. Here, we report the efficient utilization of NIR light by coupling the low-energy NIR photons with reactive biomass conversion. A unique mechanism of photothermally synergistic photocatalysis was revealed for the selective biomass conversion under NIR light. Using biomass-derived 5-hydroxymethylfurfural (HMF) conversion as a model reaction, it was found that NIR and UV-vis light featured markedly different reaction patterns. 5-Formyl-2-furancarboxylic acid (FFCA) was almost exclusively produced under NIR light, whereas UV-vis light favored the formation of 2,5-diformylfuran (DFF) as the major product. This work provides a paradigm for sustainable and selective chemical synthesis using the Earth's abundant resources, sunlight and biomass.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.